Project Grant R01AA032932
- Federal Grant Award Summary The University of New Mexico Health Sciences Center received a $160,744 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective March 9, 2026, with completion targeted for December 31, 2030. This research initiative will deliver scientific investigation into the electrophysiological mechanisms underlying cognitive control deficits associated with prenatal alcohol exposure (PAE). The...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $283,376 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) on May 15, 2026, with a completion date of April 30, 2028. This Phase 1 clinical trial will deliver research services investigating the efficacy of sensory-enriched occupational therapy intervention for children aged 6-8 years with Fetal Alcohol...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of Maryland, Baltimore a Project Grant totaling $1.74M under the Alcohol Research Programs (CFDA 93.273) to conduct basic neuroscience research examining the effects of developmental alcohol exposure on sensory cortical processing. The award, dated September 26, 2025, with a completion date of May 31, 2030, funds research investigating how fetal alcohol spectrum disorders (FASD)...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) under its Alcohol Research Programs (CFDA 93.273) awarded $585,073 to the University of North Carolina at Chapel Hill, with an award date of September 20, 2025 and completion date of August 31, 2028. This Project Grant supports research to develop and validate an innovative Fetal Alcohol Spectrum Disorders (FASD) risk assessment tool that integrates maternal and paternal risk factors with novel measures of...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded the University of Florida a $560,108 Project Grant on September 15, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a five-year investigation into the neurocognitive mechanisms of resilience to alcohol use disorder (AUD). The research will examine how attentional ability protects against AUD development in at-risk young adults with a family history of alcohol use disorder. This...
- Federal Grant Award Summary The University of Arizona received a $639,177 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective September 12, 2025, through June 30, 2030. This research project investigates the role of hepatic Forkhead Box A3 (FOXA3), a transcription factor, in the development and progression of alcohol-associated liver disease (ALD). The research team will employ...
- Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded The Ohio State University $474,223 on May 11, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct research on the mechanisms and neuroprotective targets in alcohol-induced brain injury. This project, scheduled for completion by January 31, 2031, aims to elucidate the brain region- and cell-specific mechanisms underlying alcohol-induced developmental neurotoxicity (AIDN) and...
- Federal Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) received a $596,476 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective May 1, 2026, through February 28, 2031. This award supports fundamental biomedical research investigating the role of acute phase response (APR) signaling in alcohol-associated liver disease (ALD) resolution following alcohol...
- Federal Project Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded $188,313 to the University of Tennessee Health Science Center (UTHSC) on September 26, 2025, under the Alcohol Research Programs (CFDA 93.273) to support research evaluating the synergistic effects of developmental and adult alcohol exposure on Alzheimer's disease (AD)-related phenotypes. The research project, with a completion date of August 31, 2027, investigates how ethanol exposure...
- Summary of Federal Project Grant Award The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded $733,704 to Lovelace Biomedical Research Institute on September 1, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a multimodal neuroimaging study examining the neural mechanisms underlying spatial memory deficits in children and adolescents exposed to prenatal alcohol exposure (PAE). The research employs functional magnetic resonance imaging (fMRI) and...
The University of Arkansas for Medical Sciences received a $561,966 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), effective May 1, 2026 through January 31, 2031. This research initiative investigates the role of oligodendrocyte-lineage cells and myelination in fetal alcohol spectrum disorders (FASD) by examining how ethanol exposure during critical developmental periods affects oligodendrocyte progenitor cells and mature myelinating oligodendrocytes in the developing brain. The project utilizes an established neonatal mouse model of FASD to characterize the mechanisms by which alcohol exposure alters oligodendrocyte lineage cell function and disrupts OPC-neuron interactions, with the ultimate goal of generating therapeutics to prevent and treat FASD, which affects approximately 5% of children in the United States and results in lifelong neurologic deficits without current cure. The research deliverables include detailed characterization of developmental ethanol exposure effects on oligodendrocyte lineage cell populations, distribution, and function; mechanistic insights into altered myelination patterns and aberrant OPC-synapse interactions; and foundational scientific knowledge applicable to NIAAA's mission of developing improved treatment methods and prevention strategies for alcohol-related disorders. As a comprehensive academic health sciences institution, UAMS leverages its advanced research capabilities and specialized laboratory facilities to support this fundamental and translational research addressing the neurobiological consequences of prenatal alcohol exposure.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $562.0k | 4/29/26 |